from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3045/adhC

LFCtreatmentdescriptionclass of inhibitor

-1.721

Amikacinug/mL Amikacintranslation

-2.467

Cap5-10ug/mL Capreomycintranslation

-2.910

Rox10-50 ug/mL Roxithromycintranslation

-0.690

SM2-5 ug/mL Streptomycintranslation

-2.260

Tet5-10 ug/mL Tetracyclinetranslation

-0.742

Rif0.2-5ug/mL Rifampicintranscription

-0.756

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.423

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.206

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.505

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.479

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.709

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.019

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.420

NaN30.2-2 mM Sodium aziderespiration

-0.814

Nigericin50 uM Nigericinrespiration

-0.272

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.507

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.519

menadione6-10 ug/mL Menadionerespiration

0.386

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.252

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.092

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.571

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.642

NRP_1Non-replicating persistence stage 1dosRassociated

0.057

Amp0.2mg/mL AmpicillincellWall

0.697

Cephalexin20-100 ug/mL CephalexincellWall

-0.311

Cerulenin0.32-5 ug/mL CerulenincellWall

0.560

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.503

EMB10-20 ug/mL EthambutolcellWall

0.252

Eta12-40 ug/mL EthionamidecellWall

-0.043

INH0.2-0.4 ug/mL IsoniazidcellWall

0.948

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.380

BZA0.12 mg/mL BenzamidearomaticAmides

0.860

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.849

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.706

H2O24 mM hydrogen peroxideDNAdamaging

-1.001

Levo10 ug/mL LevofloxacinDNAdamaging

-0.509

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.021

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.771

UVUV-irradiationDNAdamaging

-0.397

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.080

Antimycin12.5-50 ug/mL Antimycin A?

-0.705

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.487

PA_110-50 ug/mL Antitubercular compound PA-1?

0.511

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.208

PA8240.2-2 ug/mL PA-824?

-0.458

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.185

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.898

Verapamil50 uM Verapamil?

-1.102

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.105

methoxatin10-20 ug/mL Methoxatin?